Difficulty: Medium
Average Score: 91%
Practice
When caring for a patient with primary hyperaldosteronism, the nurse would question a health care provider's prescription for which drug?
Correct answer
A
Rationale
In the case of a patient with primary hyperaldosteronism, the correct answer to question the healthcare provider's prescription would be A) Furosemide (Lasix). This is because primary hyperaldosteronism results in excessive aldosterone production, leading to sodium and water retention, potassium excretion, and hypertension. Furosemide, a loop diuretic, would exacerbate potassium loss, which is already a concern in these patients due to aldosterone's effects on potassium excretion.
Option B) Spironolactone (Aldactone) is actually a preferred treatment for primary hyperaldosteronism as it is a potassium-sparing diuretic and an aldosterone receptor antagonist, helping to counteract the effects of excess aldosterone. Option C) Amiloride (Midamor) is another potassium-sparing diuretic and could also be considered appropriate in this scenario.
Option D) Aminoglutethimide (Cytadren) is not typically used in the treatment of primary hyperaldosteronism. Aminoglutethimide is an adrenal steroid inhibitor primarily used in the management of Cushing's syndrome.
In an educational context, understanding the rationale behind drug choices in specific endocrine disorders is crucial for nursing practice. This knowledge ensures safe and effective patient care by being able to identify appropriate medications and question prescriptions that may be contraindicated or potentially harmful in certain conditions like primary hyperaldosteronism.
Option B) Spironolactone (Aldactone) is actually a preferred treatment for primary hyperaldosteronism as it is a potassium-sparing diuretic and an aldosterone receptor antagonist, helping to counteract the effects of excess aldosterone. Option C) Amiloride (Midamor) is another potassium-sparing diuretic and could also be considered appropriate in this scenario.
Option D) Aminoglutethimide (Cytadren) is not typically used in the treatment of primary hyperaldosteronism. Aminoglutethimide is an adrenal steroid inhibitor primarily used in the management of Cushing's syndrome.
In an educational context, understanding the rationale behind drug choices in specific endocrine disorders is crucial for nursing practice. This knowledge ensures safe and effective patient care by being able to identify appropriate medications and question prescriptions that may be contraindicated or potentially harmful in certain conditions like primary hyperaldosteronism.